The implementation of pretreatment drug resistance (PDR) surveillance among people living with HIV-1 (PLWH) is a top priority in countries using efavirenz (EFV)/nevirapine (NVP) for first-line ART. In
Objectives This is the first study describing drug resistance mutations (DRM) and HIV-1 variants among infected pregnant women in Equatorial Guinea (GQ), a country with high (6.2%) and increasing HIV
Differentially expressed genes from RNA seq in parental SK-MEL-239 cells grown in normal media versus resistant SK-MEL-239 cells grown in media supplemented with vemurafenib.